No Data
No Data
Express News | The Arbitration Panel Issued A Final Award Which Found And Concluded That Aadi Bioscience Did Not Breach The EOC Pharma License Agreement And Accordingly Is Not Liable For Any Damages To EOC - Filing
Aadi Bioscience Downgraded to Neutral, Shares Fall
Piper Sandler Downgrades Aadi Biosciences(AADI.US) to Hold Rating, Cuts Target Price to $1.75
Express News | Aadi Bioscience Inc : Piper Sandler Cuts to Neutral From Overweight
Express News | Aadi Bioscience Inc - Desai Will Continue to Serve as a Member of Board
Express News | Aadi Bioscience Inc - on August 20, Neil Desai, Was Notified That His Employment as Executive Chairman of Company Will Cease on October 1, 2024